A number of PDEs have been associated with signalling pathways involved in neuropsychiatric disorders, particularly PDE4, PDE5 and PDE9, with the latter two more recently emerging as novel therapeutic targets for AD 7. Here, PDE4A is linked to Alzheimer disease.